Topics
Medulloblastoma | Treatment | Side effects | Hearing loss
Home > Publications > Topics > Medulloblastoma > Treatment > Side effects > Hearing loss
Abu-Arja
MH, Brown AL, Su JM, Okcu MF, Lindsay HB, McGovern SL, McAleer MF,
Grosshans DR, Chintagumpala MM, Paulino AC.
The
cochlear dose and the age at radiotherapy predict severe hearing
loss after passive scattering proton therapy and cisplatin in
children with medulloblastoma.
Neuro
Oncol. 2024 Jun 25:noae114. doi:
10.1093/neuonc/noae114. PMID:
38916058. Observational study˰
ˍ